Project Bio-Shield- Mandatory Vaccinations?

[Guest guest]

Though this article does not specifically go into mandatory

vaccinations, that is the buzz around this legislation...

 

My question is: if vaccinations are so effective, why do they have

to be mandatory? Let the people who don't want them take their

chances... It should be no skin off anyone elses nose, as that they

HAVE been vaccinated.

 

Other comments?

Misty L. Trepke

http://www..com

 

 

http://www.aamc.org/advocacy/library/laborhhs/labor0022.htm

 

Project Bioshield

Related Resources

P.L. 108-276

AAMC Documents

Bioterrorism Preparedness, FY 2005 Funding

Bioterrorism Preparedness, FY 2004 Funding

 

 

The President signed the Project Bioshield Act (P.L. 108-276) into

law on July 21, following final approval by the House on July 14.

The legislation authorizes funds to encourage pharmaceutical and

biotechnology companies to develop bioterrorism countermeasures.

 

First proposed in the 2003 State of the Union address, Project

Bioshield provides $5.6 billion over ten years. The final bill

guarantees this funding cannot be diverted for other purposes, but

Congress retains discretion over the program's annual

appropriations, such as the $890 million approved for FY 2004.

 

Senators Judd Gregg (R-N.H.), Joe Lieberman (D-Conn.) and Orrin

Hatch (R-Utah) are said to be working on " Bioshield II, " a bill that

will provide liability protections for firms creating vaccines or

drugs that could cause injuries.

 

Provided under the proposed Department of Homeland Security FY 2005

budget is $2.5 billion for Project Bioshield, three times the $890

million provided by Congress in FY 2004. The conference report of

the FY 2004 Homeland Security Appropriations bill was signed by the

President October 1 (P.L. 108-90) and included $890 million for

Project BioShield.

 

" Project BioShield, " first announced in the President's State of the

Union address in January, is designed to expand and speed up the

availability of vaccines and treatments to combat potential

bioterrorism agents. Under the plan, the federal government would

provide $6 billion over 10 years to create and produce vaccines and

treatments and would guarantee drug companies a buyer for these

products. In addition, the Food and Drug Administration would have

the authority to expedite the approval process for vaccines and

treatments and approve their use, prior to formal approval, in the

event of a bioterrorist attack.

 

Contact

Erica Froyd, Senior Legislative Analyst

AAMC Office of Governmental Relations

efroyd@a...

(202) 828-0525

*************************************************************